PCG Digital: Lexaria DehydraTECH 2.0 Outperforms MCT in 2021 R&D Study
PCG Digital: Lexaria DehydraTECH 2.0 Outperforms MCT in 2021 R&D Study New York, New York--(Newsfile Corp. - May 25, 2021) - PCG Digital -- The positive results keep rolling in for Lexaria (LEXX). They recently released R&D study results for three new DehydraTECH TM 2.0 formulation variations that significantly outperformed traditional MCT oil-based formulations that have become CBD industry standard. Though new to NASDAQ, Lexaria Bioscience Corp. has been producing positive test results with ...
United States New York British American Tobacco Altria Ventures Inc Lexaria Bioscience Corp York Newsfile Corp
Source: finanznachrichten.de